1-4 of 4
Soo Y Lee
Close
Sort by
Journal Articles

Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

Clinical Trials & Observations
Vivek L. Patel, Matthieu Mahévas, Soo Y. Lee, Roberto Stasi, Susanna Cunningham-Rundles, Bertrand Godeau, Julie Kanter, Ellis Neufeld, Tillmann Taube, Ugo Ramenghi, Shalini Shenoy, Mary J. Ward, Nino Mihatov, Vinay L. Patel, Philippe Bierling, Martin Lesser, Nichola Cooper, James B. Bussel
Journal: Blood
Blood (2012) 119 (25): 5989–5995.
https://doi.org/10.1182/blood-2011-11-393975
Published: 2012
Journal Articles

Standard Dose Rituximab Plus 2–4 Cycles of Pulse Dexamethasone Is Effective and Tolerable in Treatment of Immune Thrombocytopenia (ITP)

Rebecca Elstrom, MD, Waleed Ghanima, Soo Y Lee, Ithamar Turenne, James B Bussel, MD
Journal: Blood
Blood (2011) 118 (21): 1166.
https://doi.org/10.1182/blood.V118.21.1166.1166
Published: 2011
Journal Articles

Long-Term Outcome Following B-Cell Depletion Therapy with Rituximab In Children and Adults with Immune Thrombocytopenia (ITP)

Vivek L. Patel, MS, Matthieu Mahévas, MD, Roberto Stasi, MD, Susanna Cunningham-Rundles, PhD, Bertrand Godeau, MD, Soo Y. Lee, BS, Julie Kanter, MD, Ellis J. Neufeld, MD, PhD, Tillmann Taube, MD, Ugo Ramenghi, MD, Shalini Shenoy, MD, Mary J. Ward, PhD, Nino Mihatov, BS, Vinay L. Patel, BS, Philippe Bierling, MD, Nichola Cooper, MD, James B. Bussel, MD
Journal: Blood
Blood (2010) 116 (21): 72.
https://doi.org/10.1182/blood.V116.21.72.72
Published: 2010
Journal Articles

Rituximab Plus Three Cycles of Dexamethasone In the Treatment of Immune Thrombocytopenia (ITP): a Pilot Study.

Rebecca Elstrom, MD, Soo Y. Lee, BS, James B. Bussel, MD
Journal: Blood
Blood (2010) 116 (21): 3697.
https://doi.org/10.1182/blood.V116.21.3697.3697
Published: 2010